Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Adapthealth Corp

Healthcare US AHCO

9.72USD
0.07(0.73%)

Last update at 2026-06-03T20:06:00Z

Day Range

9.529.77
LowHigh

52 Week Range

7.5812.87
LowHigh

Fundamentals

  • Previous Close 9.65
  • Market Cap1651.36M
  • Volume1526025
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA586.49M
  • Revenue TTM3244.86M
  • Revenue Per Share TTM24.01
  • Gross Profit TTM 677.93M
  • Diluted EPS TTM-0.52

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -15.15400M 136.02M -723.78400M 97.90M 190.96M
Minority interest -4.75600M -4.35800M -4.20400M -3.81700M -1.97800M
Net income -70.79400M 90.42M -678.89500M 69.32M 156.18M
Selling general administrative 382.29M 359.24M 190.09M 162.12M 167.50M
Selling and marketing expenses - - 8.06M - -
Gross profit 568.56M 681.09M 681.77M 417.43M 445.61M
Reconciled depreciation 381.93M 365.33M 392.76M 351.18M 258.05M
Ebit 90.60M 262.69M -591.68500M 190.41M 225.60M
Ebitda 503.64M 628.02M -171.09100M 541.34M 481.83M
Depreciation and amortization 413.04M 365.33M 420.59M 350.93M 256.22M
Non operating income net other - - - - 31.16M
Operating income 186.27M 263.73M -598.40100M 190.41M 225.60M
Other operating expenses 3058.59M 2997.24M 3798.58M 2780.18M 2228.93M
Interest expense 105.75M 126.67M 130.30M 109.41M 95.19M
Tax provision 50.88M 41.24M -26.16000M 24.77M 32.81M
Interest income - - - - -
Net interest income -105.75300M -126.66800M -127.32200M -109.41400M -95.19500M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 50.88M 41.24M -49.00400M 24.77M 32.81M
Total revenue 3244.86M 3260.97M 3200.18M 2970.59M 2454.53M
Total operating expenses 382.29M 417.36M 1280.17M 227.01M 220.00M
Cost of revenue 2676.30M 2579.88M 2518.40M 2553.17M 2008.92M
Total other income expense net -201.42000M -127.71300M -125.38300M -92.50900M -34.64600M
Discontinued operations - - - - -
Net income from continuing ops -66.03800M 94.78M -422.77600M 73.13M 158.15M
Net income applicable to common shares - - - 63.45M 156.18M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 4316.58M 4486.95M 4619.83M 5219.59M 5250.48M
Intangible assets 85.12M 105.55M 130.16M 162.77M 202.23M
Earning assets - - - - -
Other current assets 100.62M 98.18M 69.34M 52.14M 37.44M
Total liab 2790.25M 2908.83M 3153.16M 3061.83M 3183.80M
Total stockholder equity 1518.56M 1571.14M 1458.45M 2157.76M 2066.69M
Deferred long term liab - - - - -
Other current liab 291.27M 186.93M 195.16M 134.86M 153.55M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -632.97200M -562.17800M -652.60000M 26.30M -43.02100M
Other liab - - - 344.00M 380.25M
Good will 2541.43M 2675.17M 2724.96M 3545.30M 3512.57M
Other assets - - - 300.47M 319.29M
Cash 106.14M 109.75M 77.13M 46.27M 149.63M
Cash and equivalents - - - - -
Total current liabilities 712.39M 566.99M 537.00M 456.21M 499.81M
Current deferred revenue - 34.94M 38.57M 31.64M 31.37M
Net debt 1796.66M 2020.59M 2217.52M 2282.55M 2220.97M
Short term debt 68.74M 60.51M 91.76M 67.21M 66.86M
Short long term debt 20.31M 16.25M 53.37M 35.00M 20.00M
Short long term debt total 1902.80M 2130.34M 2294.65M 2328.82M 2370.60M
Other stockholder equity 2151.44M 2131.06M 2106.68M 2122.76M 2112.05M
Property plant equipment - - - 622.01M 546.34M
Total current assets 728.90M 755.79M 649.02M 585.31M 670.06M
Long term investments - - - - -
Net tangible assets - - - -1556.91300M -1648.10900M
Short term investments - - 4.48M - -
Net receivables 370.90M 408.02M 388.91M 359.15M 359.90M
Long term debt 1715.98M 1964.92M 2094.61M 2153.27M 2183.55M
Inventory 151.25M 139.84M 113.64M 127.75M 123.09M
Accounts payable 352.38M 284.60M 211.50M 222.50M 248.03M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - 4.78M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.08M 2.25M 4.36M 8.69M -2.35400M
Additional paid in capital - - - - -
Common stock total equity - - - - 0.01M
Preferred stock total equity - - - - 0.00100M
Retained earnings total equity - - - - -43.02100M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 19.12M 17.58M 20.14M 22.41M 15.10M
Deferred long term asset charges - - - - -
Non current assets total 3587.68M 3731.16M 3970.80M 4634.28M 4580.43M
Capital lease obligations 166.50M 149.16M 146.67M 140.56M 167.04M
Long term debt total - - - - 2183.55M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments 0.00000M -310.27500M -412.65600M -411.17100M -1.12500M
Change to liabilities - - - 0.00000M -83.38300M
Total cashflows from investing activities -303.19000M -310.27500M -357.27800M -411.17100M -1824.75300M
Net borrowings -268.47800M -179.86500M -51.76900M -36.17600M 1395.57M
Total cash from financing activities -302.19200M -198.94900M -92.52800M -66.05100M 1598.74M
Change to operating activities - - - -101.48700M -108.69500M
Net income -66.03800M 94.78M -678.89500M 73.13M 158.15M
Change in cash -3.61100M 32.62M 30.86M -103.35500M 49.66M
Begin period cash flow 109.75M 77.13M 46.27M 149.63M 99.96M
End period cash flow 106.14M 109.75M 77.13M 46.27M 149.63M
Total cash from operating activities 601.77M 541.84M 480.67M 373.87M 275.68M
Issuance of capital stock - - 0.00000M 0.00000M 278.85M
Depreciation 381.93M 365.33M 420.59M 351.18M 258.05M
Other cashflows from investing activities 121.58M 5.32M - - -1620.32000M
Dividends paid - - - - 0.00000M
Change to inventory -11.49100M -28.06500M 15.53M -6.30000M -14.92000M
Change to account receivables 30.99M -26.21700M -28.86200M -0.20900M -29.69400M
Sale purchase of stock 0.00000M -2.06600M -29.27500M -13.99200M 277.28M
Other cashflows from financing activities -34.92500M -19.08400M -11.48400M -18.39300M 2189.32M
Change to netincome - - - 56.13M 3.35M
Capital expenditures 382.39M 306.06M 337.46M 391.42M 203.31M
Change receivables - - - - -29.69400M
Cash flows other operating - - - - -26.07700M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - 49.66M
Change in working capital 66.58M -26.05900M -25.10900M -107.99600M -153.30900M
Stock based compensation 21.88M 14.88M 22.47M 22.40M 25.32M
Other non cash items 150.26M 60.85M 804.20M 17.12M -34.92100M
Free cash flow 219.38M 235.78M 143.20M -17.55600M 72.37M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHCO
Adapthealth Corp		 0.07 0.73% 9.72 - 12.94 0.51 1.13 1.08 7.45
ABT
Abbott Laboratories		 0.02 0.02% 86.99 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 1.70 0.58% 295.00 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 4.20 5.69% 77.95 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 0.01 0.02% 47.69 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Adapthealth Corp

555 East North Lane, Conshohocken, PA, United States, 19428

Key Executives

Name Title Year Born
Mr. Stephen P. Griggs CEO & Director 1958
Mr. Joshua Parnes Pres & Director 1979
Mr. Jason A. Clemens C.F.A. CFO & Principal Accounting Officer 1979
Mr. Albert A. Prast Chief Technology Officer 1960
Mr. Daniel C. Bunting Chief Operating Officer of Field Operations 1962
Anton Hie VP of Investor Relations NA
Mr. Christopher J. Joyce Gen. Counsel & Sec. 1964
Ms. Wendy Russalesi Chief Compliance Officer NA
Leila Vargas Exec. VP of Sales & Marketing NA
Joel Mills Chief People Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.